Eton Pharmaceuticals (ETON) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 27, 2026

Net selling: insiders sold $9.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: -$9.3M netNet selling
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about ETON filings

Are insiders buying or selling Eton Pharmaceuticals Inc (ETON) stock?

Net selling: insiders sold $9.3M and bought $0 of ETON stock on the open market in the 90 days to Oct 27, 2026, according to SEC Form 4 filings. The largest was Brynjelsen, Sean (President & CEO), who sold $6.1M. The latest filing was on Oct 6, 2026.

Which members of Congress have traded ETON recently?

None. No member of Congress disclosed a ETON trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ETON smart-money data?

This summary uses filings available on Oct 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on ETON

Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean short3 sales · $9.3M
2 of 3 on scheduled plans. Form 4 filings.
Politicians
No recent politician filings found
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ETON filings

Are insiders buying or selling Eton Pharmaceuticals Inc (ETON) stock?

Which members of Congress have traded ETON recently?

None. No member of Congress disclosed a ETON trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ETON smart-money data?

Insiders

What insiders are doing

7 trades · 6 mo

Sold$18.9M

Sells (3)

KD
Krempa David
Chief Business Officer · Oct 6
$229K
sold
MP
Maier Paul V
Dir · Aug 28
$3.0M
sold
BS
Brynjelsen Sean
President & CEO · Aug 20
$6.1M
sold
Signals like this: n=7978, 50% finished lower at D15, median -0.1% vs SPY +0.7%

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 13, 2026

Earnings came in 126.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 13, 2026

Period ending

Jun 30, 2026

Earnings per share

$0.43+126.32% beat

$0.19 expected

Revenue

$37.6M

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 5, 2026, in 9 days

Previous reports

Period ending	Reported	EPS / estimate	EPS surprise	Revenue / income	Surprise
Jun 30, 2026	Aug 13, 2026	$0.43 / $0.19Yahoo Finance	+126.32% beat	$37.6M No estimateSEC filing	Unavailable
Mar 31, 2026	May 14, 2026	$0.14 / $0.14Yahoo Finance	+0.00% in line	$24.3M No estimateSEC filing	Unavailable
Dec 31, 2025	Mar 19, 2026	$0.19 / $0.20Yahoo Finance	-5.00% miss	$21.3M No estimate	Unavailable
Sep 30, 2025	Nov 6, 2025	$0.04 / $0.16Yahoo Finance	-75.00% miss	$22.5M No estimateSEC filing	Unavailable
Jun 30, 2025	Aug 7, 2025	-$0.10 / -$0.01Alpha Vantage	-$0.09 miss	$18.9M No estimateSEC filing	Unavailable
Mar 31, 2025	May 13, 2025	-$0.06 / $0.05Alpha Vantage	-$0.11 miss	$17.3M No estimateSEC filing	Unavailable
Dec 31, 2024	Mar 18, 2025	-$0.02 / -$0.00Alpha Vantage	-$0.02 miss	$39.0M No estimateYear ended Dec 31, 2024 · SEC filing	Unavailable
Sep 30, 2024	Nov 12, 2024	$0.02 / -$0.01Alpha Vantage	+$0.03 beat	$10.3M No estimateSEC filing	Unavailable

EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.

Open: $50.00
52-wk high: $66.37
High: $51.33
52-wk low: $14.27
Low: $49.54
Prev close: $50.00
Mkt cap: $1.43B
P/E: 125.0x
ROE: +36.0%
Fwd P/E: 13.5x
Beta: 0.90
P/S: 13.5x
P/B: 22.2x
Profit margin: +12.0%
Op margin: +35.8%

Fundamentals

Is the business strong?

Richly priced and profitable.

Net margin: 12.0%
P/E: 125.00
Forward P/E: 13.48
Market cap: $1.4B

Valuation

P/S13.53
P/B22.16

Quality

Operating margin35.8%
ROE36.0%
ROA11.9%

Growth

Beta0.90

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

25 / 100

RSI 14

26oversold

20D volatility

59%annualized

52-week range

$50.17

$14.27$66.37

20D support

$48.36recent floor

20D resistance

$59.73recent ceiling

Returns

5D +1.9%20D -15.2%60D +8.1%

Price vs moving averages

SMA20 -4.9%SMA50 -11.6%SMA200 +43.4%

Volume pace

1.22xvs prior 20D

Period ending

Reported

EPS / estimate

EPS surprise

Revenue / income

Surprise

Jun 30, 2026

Aug 13, 2026

$0.43 / $0.19Yahoo Finance

+126.32% beat

$37.6M No estimateSEC filing

Unavailable

Mar 31, 2026

May 14, 2026

$0.14 / $0.14Yahoo Finance

+0.00% in line

$24.3M No estimateSEC filing

Unavailable

Dec 31, 2025

Mar 19, 2026

$0.19 / $0.20Yahoo Finance

-5.00% miss

$21.3M No estimate

Unavailable

Sep 30, 2025

Nov 6, 2025

$0.04 / $0.16Yahoo Finance

-75.00% miss

$22.5M No estimateSEC filing

Unavailable

Jun 30, 2025

Aug 7, 2025

-$0.10 / -$0.01Alpha Vantage

-$0.09 miss

$18.9M No estimateSEC filing

Unavailable

Mar 31, 2025

May 13, 2025

-$0.06 / $0.05Alpha Vantage

-$0.11 miss

$17.3M No estimateSEC filing

Unavailable

Dec 31, 2024

Mar 18, 2025

-$0.02 / -$0.00Alpha Vantage

-$0.02 miss

$39.0M No estimateYear ended Dec 31, 2024 · SEC filing

Unavailable

Sep 30, 2024

Nov 12, 2024

$0.02 / -$0.01Alpha Vantage

+$0.03 beat

$10.3M No estimateSEC filing

Unavailable

Eton Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about ETON filings

Smart money on ETON

Questions about ETON filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 126.3% above what analysts expected.

Estimated report: Nov 5, 2026, in 9 days

Previous reports

Is the business strong?

Price structure

Eton Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about ETON filings

Smart money on ETON

Questions about ETON filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 126.3% above what analysts expected.

Estimated report: Nov 5, 2026, in 9 days

Previous reports

Is the business strong?

Price structure

Eton Pharmaceuticals Inc

Overview

Questions about ETON filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals

Eton Pharmaceuticals Inc

Overview

Questions about ETON filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals